Chemclene Dodges Cash Payout by Selling Land to Clean Up Toxic Site
Published Date: 8/29/2025
Notice
Summary
The government and Chemclene Corporation are updating a 2006 agreement about cleaning up a polluted site in Pennsylvania. Instead of paying a lump sum, Chemclene will sell two properties for about $1.1 million, with the government getting $1,073,373 from the sale. People have a chance to comment on this change before it’s finalized.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Consent Decree Settled by Property Sale
The Department of Justice lodged a proposed change to a 2006 consent decree that would let Chemclene Corporation sell two properties for $1,100,000 to East Whiteland Township. If approved, the United States will receive $1,073,373 from the sale to satisfy the Settling Defendants' obligation that otherwise could have been a $1,417,200 lump-sum payment plus interest.
Public Comment Opportunity on Modification
The public may comment on the proposed consent-decree modification. All comments must be submitted no later than thirty (30) days after publication (publication date August 29, 2025); comments may be emailed to [email protected] or mailed to Assistant Attorney General, U.S. DOJ--ENRD, P.O. Box 7611, Washington, DC 20044-7611, and the proposed modification can be downloaded from the Justice Department website.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-12143 — Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
AndersonBrecon, Inc. DBA PCI Pharma Services wants to become an official importer of certain controlled substances, including some strong drugs like tetrahydrocannabinols. People and companies involved with these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could impact how these substances are brought into the U.S., but no costs or fees were mentioned yet.
2026-12213 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement With Change to a Previously Approved Collection Title-International Terrorism Victim Expense Reimbursement Program Application
The Department of Justice is bringing back and updating the application form for the International Terrorism Victim Expense Reimbursement Program. This affects victims of international terrorism who seek help covering their expenses. The DOJ wants your feedback by July 17, 2026, to make sure the form is clear, useful, and easy to fill out—no extra hassle or hidden costs involved!
2026-12144 — Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Wedgewood Pharmacy LLC wants to become an official importer of certain strong controlled substances, like Etorphine HCL and Thiafentanil. This affects drug manufacturers and others in the supply chain who can comment or request a hearing by July 17, 2026. No direct costs are mentioned, but the decision could impact how these drugs enter the U.S. market.
Previous / Next Documents
Previous: 2025-16590 — Agency Information Collection Activity Under OMB Review: Application for Veteran Readiness and Employment Benefits for Claimants With Service-Connected Disabilities (Chapter 31, Title 38, U.S.C.)
The Veterans Benefits Administration is updating the form veterans with service-connected disabilities use to apply for Readiness and Employment benefits. This update is being reviewed to make sure the form is clear and easy to use, with no extra costs or delays expected. Veterans applying for these benefits should see a smoother process soon!
Next: 2025-16592 — Agency Information Collection Activity Under OMB Review: Claim for Disability Insurance Benefits, Government Life Insurance
The Veterans Benefits Administration is updating the form you use to claim disability insurance and government life insurance benefits. If you’re a veteran or family member applying for these benefits, this means a smoother, clearer process soon. The government is checking the paperwork to make sure it’s easy to use and doesn’t waste your time or money.